Clin2
NCT07035821Possibly a fitNot yet recruiting

Olanzapine for vomiting in children after chemotherapy

Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric PatientsPediatric Cancer

Treatments studied

Part of Cancer clinical trials.

This trial tests whether the drug olanzapine can reduce breakthrough vomiting in children who still vomit despite standard preventive medicines. It aims to improve comfort during cancer treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
100 people
Ages
5 years to 18 years
Study type
Interventional

Who can take part

  • Age 5 to 18 years
  • Current cancer diagnosis and receiving chemotherapy
  • Currently taking preventive anti-nausea medicines (like ondansetron, aprepitant, dexamethasone)
  • Still have vomiting despite these medicines
  • Weigh at least 10 kg (about 22 pounds)
  • Be well enough to carry out daily activities (performance score above 50 or ECOG less than 3)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07217600Recruiting· Phase 4
Preventing vomiting during kids' radiation therapy

This trial tests a new, easy-to-take film that melts on the tongue to prevent vomiting caused by radiation therapy in children with cancer. It may be a good option if your child is getting radiation to the belly or spine and has trouble swallowing pills.

Chongqing, Chongqing Municipality
NCT07413809Recruiting· Phase 3
Preventing nausea after stem cell transplant: olanzapine vs dexamethasone

This trial compares two anti-nausea drug regimens (one with olanzapine, one with dexamethasone) to prevent delayed nausea and vomiting after a stem cell transplant for multiple myeloma. It aims to find which is better at controlling these side effects.

Ningbo, Zhejiang
NCT06850454Recruiting· Phase 3
Olanzapine vs placebo for nausea from first chemo

This study tests if the drug olanzapine (commonly used for nausea) can help prevent vomiting in people receiving moderately strong chemotherapy for the first time. It may be a good fit if you're about to start treatment with oxaliplatin, irinotecan, or carboplatin and haven't had severe nausea treatments before.

Bangkok, Bangkok
NCT07581405Not yet recruiting· Phase 2
Olanzapine to ease side effects of stomach cancer chemotherapy

This trial tests whether the drug olanzapine can help reduce side effects of chemotherapy when given before surgery for stomach cancer, potentially helping patients feel better and complete their treatment.

Chicago, Illinois
NCT07633236Recruiting· Phase 3
Olanzapine to prevent appetite and weight loss during cancer chemotherapy

This study tests whether olanzapine, a medication that can increase appetite, helps prevent severe appetite loss and muscle wasting in patients with ovarian or stomach cancer who are receiving chemotherapy before surgery. The goal is to help patients maintain nutrition and strength during treatment.

Moscow
NCT06995508Recruiting· Phase 2
Olanzapine for appetite loss in head and neck cancer patients

This trial tests if the drug olanzapine can help improve appetite in people with head and neck cancer who are getting chemotherapy and radiation. It aims to prevent or reduce weight loss during treatment.

Buffalo, New York

Hear when a new Pediatric Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.